Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The potassium channel subfamily K member ACh, commonly referred to as IKACh, is a cardiac potassium ion channel that plays a crucial role in regulating heart rate. It is specifically activated by acetylcholine through muscarinic receptors and is responsible for the acetylcholine-dependent slowing of the heart rate. It is a heteromultimeric complex composed of GIRK1 and CIR/GIRK4 subunits. Activation leads to an increase in potassium conductance across the cell membrane, resulting in hyperpolarization and decreased excitability of cardiac pacemaker cells. Dysfunctions can contribute to arrhythmias or abnormal heart rates due to impaired parasympathetic control.
Activation of muscarinic M2 receptors by acetylcholine leads to G protein activation and subsequent direct binding of Gβγ-subunits to the IKACh channel, causing channel opening and increased potassium conductance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member ACh (IKACh).